SignalHF vs prolaio eVO2peak Module
AI Verdict
Choose SignalHF if…
Choose SignalHF if your primary goal is to proactively prevent heart failure hospitalizations in patients with cardiac implantable electronic devices (CIEDs). This tool is ideal for care teams seeking an FDA-cleared AI algorithm that analyzes CIED data to generate early alerts and enable timely interventions based on a 30-day hospitalization risk prediction. It's particularly suited for unifying data from various CIED manufacturers and streamlining alert management for high-risk patients.
View SignalHF →Choose prolaio eVO2peak Module if…
Choose prolaio eVO2peak Module if you need to estimate a patient's peak oxygen consumption (eVO2peak) using real-world data from FDA-cleared wearable medical sensors. This module is best suited for clinicians and researchers looking for an adjunctive aid in evaluating cardiovascular fitness, guiding exercise prescriptions, or monitoring functional capacity longitudinally, especially when leveraging data from remote, non-invasive sensors for high-density data collection.
View prolaio eVO2peak Module →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | SignalHF | prolaio eVO2peak Module |
|---|---|---|
| Pricing | Contact for pricing | Unknown |
| Deployment | SaaS | Cloud |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
SignalHFSignalHF (Tool A) is designed with features like automatic alerts, a unified platform for CIED data, and AI-driven alert management, indicating a focus on streamlining clinical workflows and providing actionable insights directly to care teams. In contrast, the prolaio eVO2peak Module (Tool B) is described as a software-only module lacking its own user interface, requiring integration into external systems for output display, suggesting a less direct end-user experience.
Clinical Value
SignalHFSignalHF (Tool A) offers a direct and critical clinical impact by predicting heart failure hospitalizations within 30 days, with studies suggesting a reduction in all-cause mortality and hospitalizations. While the prolaio eVO2peak Module (Tool B) provides valuable eVO2peak estimations for cardiovascular assessment and research, its role is explicitly stated as an 'adjunctive aid' and not for diagnosis or active monitoring. SignalHF's predictive power for acute events and demonstrated impact on patient outcomes provides a stronger clinical value for immediate patient management.
Pricing & Value
TieBoth tools require direct contact with the company for pricing information, making a transparent cost comparison impossible. Both offer significant value by addressing high-cost areas in healthcare: SignalHF aims to reduce expensive heart failure hospitalizations, while prolaio eVO2peak Module seeks to improve efficiency and insights in cardiovascular research.
Enterprise Readiness
SignalHFBoth tools demonstrate strong enterprise readiness with FDA clearance, HIPAA compliance, BAA availability, and cloud-based deployment. SignalHF (Tool A) specifically highlights its manufacturer-agnostic compatibility with various major Cardiac Implantable Electronic Device (CIED) brands, offering a unified platform for diverse device data. This broad compatibility for existing infrastructure gives SignalHF a slight advantage in enterprise integration within cardiology practices.
Innovation
SignalHFSignalHF (Tool A) is highly innovative for its FDA-cleared, manufacturer-agnostic AI algorithm that predicts heart failure hospitalizations within 30 days, enabling proactive intervention and being the first pacemaker-compatible heart failure algorithm on the market. Prolaio eVO2peak Module (Tool B) also shows innovation by using a locked deep-learning model to estimate eVO2peak from real-world wearable data for longitudinal physiological assessment. However, SignalHF's focus on predicting acute, high-impact events across a wide range of existing devices gives it a slight edge in immediate clinical innovation and broader applicability to current infrastructure.
Support & Docs
TieBoth tools mention the availability of 'instructions for use' or 'documentation for integration' as part of their regulatory compliance. However, neither the provided structured facts nor the web search results offer specific details regarding dedicated customer support channels, comprehensive online documentation portals, or structured training programs. Therefore, based on the available information, it is not possible to distinguish between the two.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | SignalHF | prolaio eVO2peak Module |
|---|---|---|
| Tool Name | SignalHF | prolaio eVO2peak Module |
| Company | Implicity | Prolaio |
| Description | FDA-cleared AI algorithm that predicts heart failure hospitalizations within 30 days by analyzing data from various cardiac implantable electronic devices, enabling early intervention and personalized care. | FDA-cleared software to estimate peak oxygen consumption using real-world patient data for cardiovascular research and care. |
| Primary Function | Predicts heart failure hospitalizations within 30 days. | Estimates peak oxygen consumption (eVO2peak). |
| Data Input / Compatibility | Manufacturer-agnostic compatibility with various CIEDs (pacemakers, ICDs, CRTs); analyzes physiological data, demographics, lead measurements, episodes, and therapies. | Utilizes demographic data, single-lead ECG, and triaxial accelerometry inputs; processes data from qualified third-party FDA-cleared wearable medical sensors. |
| Key Output/Alerts | Generates automatic alerts for care teams based on risk scores; AI-driven alert management to filter and highlight relevant events. | Provides information as an adjunctive aid in clinical evaluation. |
| Specialties | Cardiology | Cardiology, Physical Medicine & Rehab, Sports Medicine |
Videos
Demos, reviews, and walkthroughs featuring SignalHF and prolaio eVO2peak Module.